About Nexus Pharmaceuticals
Nexus Pharmaceuticals is a Healthcare company based in Vernon Hills (United States) founded in 2003, and was acquired by Pharmaceutical Associates in November 2026. Injectable generic and specialty drugs are manufactured with innovative processes. It operates on a Direct-to-Consumer (D2C) model. Its chief executive, as recorded, is Mariam Darsot. Nexus Pharmaceuticals offers products and services including EMERPHED® RTU. Its focus areas include Pharmaceuticals and Generic and Specialty Drugs. Its legal entity is Nexus Pharmaceuticals, LLC.
Company details
Nexus Pharmaceuticals, a US-based pharmaceutical manufacturer, is dedicated to the development and deployment of lifesaving, critical-need drugs. Operating in the generic and specialty injectable drug industry since 2003, the company addresses unmet medical needs by providing reliable treatment options. Their efforts are centered on ensuring that essential medications are available when and where they are most needed.
- Headquarters Vernon Hills, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nexuspharma.net
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Pharmaceutical Associates (Nov 2026)
- Legal Name Nexus Pharmaceuticals, Llc
- Investors
- Acquired by
Products & Services of Nexus Pharmaceuticals
Nexus Pharmaceuticals offers a comprehensive portfolio of products and services, including EMERPHED® RTU.
Ephedrine sulfate injection is provided for emergency use.
Apps and channels of Nexus Pharmaceuticals
its YouTube channel Nexus Pharmaceuticals, LLC has 590 subscribers and 14 videos.
Videos from Nexus Pharmaceuticals
The most watched videos on Nexus Pharmaceuticals's YouTube channel, Nexus Pharmaceuticals, LLC (590 subscribers). Click a video to play it here.
More on Nexus Pharmaceuticals, LLC.
Investors in Nexus Pharmaceuticals
Nexus Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Pharmaceutical Associates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Generic liquid drugs are manufactured by Pharmaceutical Associates. | 1968 | paipharma.com | Greenville, United States |
Investor details for Nexus Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nexus Pharmaceuticals
14 people are tracked at Nexus Pharmaceuticals (8 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Mariam Darsot | CEO | Leadership |
Usman Ahmed | President and Chief Executive Officer | Leadership |
Trenton Lovell | Senior Director, Sales, National Accounts And Trade Relations | Leadership |
Lara S. | Director, Information Technology | Leadership |
Omair Ahmed | Chief Operating Officer | Leadership |
Vince Lopiccolo | Vice President Sales Marketing | Leadership |
Dan Geffen | Senior Director, Sales, National Accounts And Trade Relations | Leadership |
Chris Conroy | Director, National Accounts | Leadership |
Angie Amarei | Senior Manager, Quality Control | Team |
Richa Rayamajhi | Sr. Business Intelligence Analyst | Team |
Chris Wilburn | Manager, Pricing & Contracts | Team |
Rebecca Bianchi | Associate Lead/lab Coordinator | Team |
Legi Jacob | Manager, API And Stability | Team |
Dale Beninato | Senior Validation Engineer | Team |
Complete people profiles for Nexus Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nexus Pharmaceuticals
3 dated milestones of Nexus Pharmaceuticals across 23 years, from founding to its latest funding, stage changes and deals.
- Founded Nexus Pharmaceuticals is founded.
- Exit Acquired by Pharmaceutical Associates.
- Exit Acquired by Pharmaceutical Associates.
Web traffic of Nexus Pharmaceuticals
The website of Nexus Pharmaceuticals (nexuspharma.net) receives about 3.5K visits a month.
- Monthly visits3.5K
▲ 52.3% vs previous month
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Nexus Pharmaceuticals (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nexus Pharmaceuticals
Nexus Pharmaceuticals was founded in 2003.
Nexus Pharmaceuticals is headquartered in Vernon Hills, United States. It is registered at Vernon Hills, Illinois, United States.
Mariam Darsot is the CEO of Nexus Pharmaceuticals, as recorded in our data.
Nexus Pharmaceuticals, a US-based pharmaceutical manufacturer, is dedicated to the development and deployment of lifesaving, critical-need drugs. Operating in the generic and specialty injectable drug industry since 2003, the company addresses unmet medical needs by providing reliable treatment options. Their efforts are centered on ensuring that essential medications are available when and where they are most needed.
Nexus Pharmaceuticals offers EMERPHED® RTU.
Nexus Pharmaceuticals has 1 investor. Key investors include Pharmaceutical Associates.
Nexus Pharmaceuticals operates through Nexus Pharmaceuticals, Llc.
Yes. Nexus Pharmaceuticals was acquired by Pharmaceutical Associates in November 2026.
